Immunex Corporation Research Articles

4845198 Hybridoma antibody which binds IL-2 receptor: David Urdal, Carl March, Steven Dower assigned to Immunex Corporation

4845198 Hybridoma antibody which binds IL-2 receptor: David Urdal, Carl March, Steven Dower assigned to Immunex Corporation

4703004 Synthesis of protein with an identification peptide: Thomas P Hopp, Susan L Bektesh, Paul J Conlon, Carl March assigned to Immunex Corporation

4703004 Synthesis of protein with an identification peptide: Thomas P Hopp, Susan L Bektesh, Paul J Conlon, Carl March assigned to Immunex Corporation

Molecular Modification of Lymphokines by in Vitro Mutagenesis

Annals of the New York Academy of SciencesVolume 507, Issue 1 p. 22-31 Molecular Modification of Lymphokines by in Vitro Mutagenesis S. K. DOWER, Corresponding Author S. K. DOWER Immunex Corporation Seattle, Washington 98101Address for correspondence: S. K. Dower, Immunex Corporation, 51 University Street, Seattle, Washington 98101.Search for more papers by this authorBRUCE MOSLEY, BRUCE MOSLEY Immunex Corporation Seattle, Washington 98101Search for more papers by this authorP. J. CONLON, P. J. CONLON Immunex Corporation Seattle, Washington 98101Search for more papers by this authorP. BENSON, P. BENSON Immunex Corporation Seattle, Washington 98101Search for more papers by this authorC. GRUBIN, C. GRUBIN Immunex Corporation Seattle, Washington 98101Search for more papers by this authorA. LARSEN, A. LARSEN Immunex Corporation Seattle, Washington 98101Search for more papers by this authorS. GILLIS, S. GILLIS Immunex Corporation Seattle, Washington 98101Search for more papers by this authorD. COSMAN, D. COSMAN Immunex Corporation Seattle, Washington 98101Search for more papers by this author S. K. DOWER, Corresponding Author S. K. DOWER Immunex Corporation Seattle, Washington 98101Address for correspondence: S. K. Dower, Immunex Corporation, 51 University Street, Seattle, Washington 98101.Search for more papers by this authorBRUCE MOSLEY, BRUCE MOSLEY Immunex Corporation Seattle, Washington 98101Search for more papers by this authorP. J. CONLON, P. J. CONLON Immunex Corporation Seattle, Washington 98101Search for more papers by this authorP. BENSON, P. BENSON Immunex Corporation Seattle, Washington 98101Search for more papers by this authorC. GRUBIN, C. GRUBIN Immunex Corporation Seattle, Washington 98101Search for more papers by this authorA. LARSEN, A. LARSEN Immunex Corporation Seattle, Washington 98101Search for more papers by this authorS. GILLIS, S. GILLIS Immunex Corporation Seattle, Washington 98101Search for more papers by this authorD. COSMAN, D. COSMAN Immunex Corporation Seattle, Washington 98101Search for more papers by this author First published: December 1987 https://doi.org/10.1111/j.1749-6632.1987.tb45789.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume507, Issue1Biological Approaches to the Controlled Delivery of DrugsDecember 1987Pages 22-31 RelatedInformation

Lymphokine-driven "differentiation" of cytotoxic T-cell clones into cells with NK-like specificity: correlations with display of membrane macromolecules.

Immunological ReviewsVolume 72, Issue 1 p. 43-72 Lymphokine-Driven “Differentiation” of Cytotoxic T-Cell Clones into Cells with NK-Like Specificity: Correlations with Display of Membrane Macromolecules Colin G. Brooks, Colin G. Brooks Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.Search for more papers by this authorDavid L. Urdal, David L. Urdal Immunex Corporation, 51 University Bldg. Seattle, Washington 98101.Search for more papers by this authorChristopher S. Henney, Christopher S. Henney Immunex Corporation, 51 University Bldg. Seattle, Washington 98101.Search for more papers by this author Colin G. Brooks, Colin G. Brooks Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.Search for more papers by this authorDavid L. Urdal, David L. Urdal Immunex Corporation, 51 University Bldg. Seattle, Washington 98101.Search for more papers by this authorChristopher S. Henney, Christopher S. Henney Immunex Corporation, 51 University Bldg. Seattle, Washington 98101.Search for more papers by this author First published: June 1983 https://doi.org/10.1111/j.1600-065X.1983.tb01072.xCitations: 121AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume72, Issue1June 1983Pages 43-72 RelatedInformation